Investigation of Epigenetic Dysregulation in Lupus NK Cells
Investigation of Epigenetic Dysregulation in Lupus NK Cells
批准号:
10194280
负责人:
PAUL JOSEPH UTZ
金额:
$23.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-03 至 2023-02-28
关键词:
AffectAntigen-Antibody ComplexAtlasesBenchmarkingBiologicalBiological AssayBlood donorCell Adhesion MoleculesCell CompartmentationCell physiologyCell surfaceCell-Mediated CytolysisCellsCellular biologyChIP-seqCharacteristicsChromatinClinicalClinical ResearchComplexCytometryDNA MethylationDNA Sequence AlterationDataData SetDevelopmentDiseaseEpigenetic ProcessFluorescence-Activated Cell SortingFoundationsFrequenciesFunctional disorderFutureGeneticGenomicsGoalsGranzymeHeterogeneityHistone AcetylationHistone DeacetylaseHistonesImmuneImmune ToleranceImmune responseImmune systemIndividualInterferon Type IIInterventionInvestigationLightLinkLupusLysineMHC Class I GenesMeasuresMediatingMethodsModelingMolecularMonitorMonozygotic twinsNK Cell ActivationNatural Killer CellsOther GeneticsOutcomePathologicPatientsPatternPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologyPhenotypePlayPopulationProductionProteomicsReceptor CellRefractoryRegulationResolutionRoleSamplingSystemic Lupus ErythematosusTNF geneTechnologyTestingTherapeutic InterventionTransposaseVirus DiseasesVorinostatantibody-dependent cell cytotoxicitybaseclinically significantcytokinecytotoxicitydisease heterogeneitydisorder riskepigenetic markerepigenetic variationepigenomicsgenomic locushealthy volunteerhigh dimensionalityhigh rewardhigh riskhistone modificationhuman diseaseimmune functionindexinginnovationinsightnovelnovel therapeuticsperforinperipheral bloodreceptorsingle cell analysissingle cell technologysystemic inflammatory response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overarching goal of this proposal is to systematically characterize an epigenetically distinct natural
killer (NK) cell population with hypoacetylated histones. This NK cell subset is reduced in frequency in systemic
lupus erythematosus (SLE) patients with increased disease activity. We will test the hypothesis that this NK cell
subset, which we term “NKSLE cells”, has a distinct cell surface molecule profile, and is functionally different from
other NK cells in cytolytic capacity and cytokine secretion upon activation. We will further examine if NK cell
functions can be altered by experimental manipulation of histone acetylation. Our data will lay a strong foundation
for future epigenomic studies on specific genes or genomic loci pivotal for lupus pathophysiology. The advent of
single-cell technologies has greatly accelerated our understanding of immune system heterogeneity. Increasing
evidence supports a compelling model in which pathologically important cells in SLE may represent only a small
fraction of the highly complex immune system. This proposal builds upon this innovative concept, and will
leverage cutting-edge technologies to interrogate the epigenetic and proteomic heterogeneity of NK cells, and
their complex relationships. In Aim 1, we will employ highly multiplexed mass cytometry to monitor a broad array
of functionally important NK cell markers, such as activating and inhibitory receptors, cell adhesion molecules,
and those indicative of cytotoxicity activity, and histone acetylation abundance in individual NK cells. We will first
benchmark NK cell heterogeneity in healthy blood donors, with a goal to identify cellular features associated with
global histone acetylation level. Next, we will extend the analysis to SLE patients, whose NK cell compartments
show reduced representation of cells with hypoacetylated histones. This study will reveal the phenotypic and
functional characteristics of NKSLE cells. In Aim 2, we will investigate the functional differences between NK cells
with differential histone acetylation content. Cytotoxicity and proinflammatory cytokine secretion are key
immunological functions mediated by NK cells during a viral infection. Mass cytometry will be utilized to examine
how differential histone acetylation abundance in individual NK cells is correlated with the degree of their immune
response upon activation measured by degranulation markers, and cytokine production. Our analysis will first
focus on NK cells isolated from healthy volunteers, and subsequently extend to those from lupus patients to
better understand the clinical significance of NKSLE cell reduction in lupus. Lastly, as opposed to genetic
mutations that are generally refractory to therapeutic interventions, epigenetic phenomena are largely reversible,
making them attractive targets for developing new drugs. We will investigate the plasticity of NK cell functions
by pharmacologically manipulating histone acetylation. Together, our proposal will provide new insights into the
biological and pathological significance of histone acetylation in NK cell molecular and functional phenotypes.
Our data will be valuable for future studies on lupus and other human diseases in which NK cells play important
pathological roles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Histone Landscape Profiles in HIV
-
批准号:10535173
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2022
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Investigation of Epigenetic Dysregulation in Lupus NK Cells
-
批准号:10363743
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2021
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
-
批准号:10317652
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2020
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
-
批准号:9975682
-
项目类别:
-
资助金额:$84.2万
-
财政年份:2016
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
-
批准号:9753117
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2016
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
-
批准号:9539943
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2016
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
ACE: Autoimmunity Center of Excellence (ACE) at Stanford
-
批准号:8680545
-
项目类别:
-
资助金额:$74.35万
-
财政年份:2014
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
ACE: Autoimmunity Center of Excellence (ACE) at Stanford
-
批准号:9266354
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2014
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Measuring Influenza and H1N1 vaccine responses in immunodeficient patients
-
批准号:8306395
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2011
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Th17 lymphocytes in human autoimmune diseases
-
批准号:7688799
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2009
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:7235172
-
项目类别:
-
资助金额:$4.19万
-
财政年份:2006
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Lysate Arrays for Studying the Diabetes Proteome
-
批准号:7140639
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2005
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Training Program in Adult and Pediatric Rheumatology
-
批准号:8262328
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2005
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Lysate Arrays for Studying the Diabetes Proteome
-
批准号:7021497
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2005
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:6800294
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2003
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:7153488
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2002
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:6574168
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2002
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:6830759
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2002
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Multiplex Autoantibody Profiling in SLE
-
批准号:6688436
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2002
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
Autoantigen Arrays to Select Vaccines for Model of PBC
-
批准号:6561923
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2002
-
负责人:PAUL JOSEPH UTZ
-
依托单位:
海外基金